The "AI trade" remains the dominant market narrative, making NVIDIA (NVDA) a core holding while secondary opportunities emerge in power/energy and memory infrastructure.

Retail investors seeking exposure to the private AI giant Anthropic should look to public proxies Zoom (ZM) and SK Telecom (SKM), which hold significant stakes in the company.

In the crypto sector, monitor the MegaETH (MEGA) token launch on April 30th (estimated $1.2B–$1.5B valuation) and watch for a potential "seller exhaustion" bounce in Layer Zero (ZRO) near the $1.40 level.

The healthcare sector is seeing a massive shift toward peptides and weight-loss drugs, positioning Eli Lilly (LLY) as a primary beneficiary of this long-term trend.

Within collectibles, focus on "Grail" assets like Azuki and Bored Ape Yacht Club (BAYC), as liquidity shifts from high-friction physical cards back into established digital NFT IPs.

NVIDIA (NVDA)

• NVIDIA has reached a market capitalization of over $5 trillion, which is currently double the entire market cap of the cryptocurrency sector ($2.54 trillion). • The stock continues to hit all-time highs, driven by the massive demand for AI compute and infrastructure.

Takeaways

• AI Dominance: The "AI trade" remains the strongest narrative in traditional markets, significantly outperforming crypto assets in the near term. • Sector Bottlenecks: Investors should look beyond just chips; the current bottlenecks for AI growth are power/energy and memory, which present secondary investment opportunities.

Anthropic & OpenAI

• Anthropic and OpenAI are both seeing private market valuations exceeding $1 trillion. • Anthropic is noted for its rapid product rollout (Claude Opus/3.5) and is gaining significant traction among power users. • OpenAI reportedly missed some internal revenue and user growth benchmarks, with concerns regarding the $1.4 trillion needed for data center expansion over the next decade. • Subsidization Risk: Current AI tools are heavily subsidized; for example, a $200/month plan may cost the provider $5,000 in compute, suggesting future price hikes or usage limits are likely.

Takeaways

• Public Proxies: For retail investors seeking exposure to Anthropic (which is private), the transcript suggests researching Zoom (ZM) and SK Telecom (SKM), as both companies hold significant private stakes in Anthropic. • Productivity Boom: The primary value proposition remains a "productivity boom" in coding, healthcare, and middle management, rather than a total job wipeout.

Bitcoin (BTC) & Ethereum (ETH)

• Bitcoin is trading around $76,000, while Ethereum is at $2,278. • Quantum Concern: A major "dark cloud" over Bitcoin is the threat of Quantum Computing. Proposals like BIP 361 suggest freezing old, vulnerable addresses (including Satoshi’s coins) to prevent theft, which could effectively act as a massive supply cut. • DeFi Recovery: The Aave ecosystem successfully filled a $200 million bad debt gap through community donations, showing resilience in decentralized finance despite recent exploits.

Takeaways

• MegaETH (MEGA): A major upcoming catalyst is the MegaETH TGE (Token Generation Event) on April 30th. It is expected to launch with a Fully Diluted Valuation (FDV) between $1.2B and $1.5B. • Layer Zero (ZRO): Sentiment is currently bearish/neutral as the team was perceived as slow to react during recent DeFi exploits, though some investors are holding for a potential "seller exhaustion" bounce around $1.40.

Collectibles: NFTs & Trading Cards

• Physical Cards: Pokemon and sports cards are seeing "parabolic" price action. Some vintage Pokemon sets are up 2x-5x since January 2026. • NFT Comeback: High-end NFT collections are seeing a resurgence. Azuki is up 60% on the week, and Bored Ape Yacht Club (BAYC) is seeing renewed interest under new leadership (Figge).

Takeaways

• Digital vs. Physical: The friction of physical trading (shipping, grading, eBay fees) is driving collectors back to NFTs for ease of liquidity and "instant" trading. • Grail Focus: The recovery is currently concentrated in "Grail" assets and established IP rather than new "mint-and-flip" projects.

Healthcare & Peptides

• A new investment theme is emerging around Peptides and weight-loss drugs (GLP-1s). • Eli Lilly (LLY): Mentioned as a primary benefactor of the peptide trend, currently trading at a slight discount from all-time highs. • Gray Market vs. Official: There is a massive price discrepancy (up to 90% cheaper) between "gray market" peptides and official prescriptions, though this carries significant medical and regulatory risk.

Takeaways

• Personalized Medicine: The intersection of AI and Healthcare is viewed as a major growth sector, specifically using AI to manage personalized peptide protocols and nutrition. • Risk Factor: Investors and users are cautioned to perform extensive blood work (specifically cancer screenings) before engaging with peptides like BPC-157, as they can accelerate existing cell growth.

Macro Outlook

• Federal Reserve: Jerome Powell is expected to step down, with Kevin Warsh likely to take over. Warsh is viewed as an "inflation hawk," which could be bearish for markets in the short term but bullish for long-term stability. • Oil Prices: The UAE's withdrawal from OPEC has caused oil price spikes, which remains a primary indicator for persistent inflation. • Interest Rates: Expectations for rate cuts in 2026 have dropped significantly (only a 20% chance of a cut by year-end).